Enable Injections Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Enable Injections Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10421
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enable Injections Inc (Enable Injections) is a medical device company that manufactures and develops disposable body-worn bolus injector to deliver high viscosity payloads to the subcutaneous tissue. The company develops delivery device, delivery systems, and injector systems including vial transfer systems, syringe transfer systems, enable injector, and fully-automated reconstitution systems. Its enable injector is an automatic device offering controlled and comfortable flow of drug. Enable Injections’ reconstitution system is a fully automated mixing and transfer system that mixes vials of liquid, liquid and powder and makes easier for injection. The company offers its products to individuals, doctors, and pharmaceutical and biotechnology industry. It operates through medical device companies and medical device design engineers. Enable Injections is headquartered in Cincinnati, Ohio, the US.

Enable Injections Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enable Injections Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Enable Injections Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Enable Injections Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Enable Injections Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Enable Injections Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Enable Injections Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Enable Injections Raises Funds Through Series B Financing 10
Enable Injections Raises USD30 Million in Series A Financing 12
Enable Injections Raises USD10 Million in Venture Financing 13
Enable Injections Secures Venture Funding 14
Enable Injections Raises USD2 Million in Venture Financing 15
Partnerships 16
Enable Injections Enters into Co-Development Agreements with UCB and Apellis Pharma 16
Enable Injections Enters into Partnership with Flextronics International 17
CSL Behring Enters into Co-Development Agreement with Enable Injections 18
Enable Injections Inc – Key Competitors 19
Enable Injections Inc – Key Employees 20
Enable Injections Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Legal and Regulatory 22
Jan 08, 2018: Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products 22
Product News 23
Feb 06, 2018: Covestro plastic enables medical device innovation 23
Jun 20, 2017: Enable Injections launches multi-vial/multi-syringe biologics delivery system 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Enable Injections Inc, Medical Equipment, Key Facts 2
Enable Injections Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Enable Injections Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Enable Injections Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Enable Injections Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Enable Injections Inc, Deals By Market, 2012 to YTD 2018 8
Enable Injections Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Enable Injections Raises Funds Through Series B Financing 10
Enable Injections Raises USD30 Million in Series A Financing 12
Enable Injections Raises USD10 Million in Venture Financing 13
Enable Injections Secures Venture Funding 14
Enable Injections Raises USD2 Million in Venture Financing 15
Enable Injections Enters into Co-Development Agreements with UCB and Apellis Pharma 16
Enable Injections Enters into Partnership with Flextronics International 17
CSL Behring Enters into Co-Development Agreement with Enable Injections 18
Enable Injections Inc, Key Competitors 19
Enable Injections Inc, Key Employees 20

List of Figures
Enable Injections Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Enable Injections Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Enable Injections Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Enable Injections Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Enable Injections Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Enable Injections Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Enable Injections Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Enable Injections Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Enable Injections Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zalando SE:企業の戦略・SWOT・財務分析
    Zalando SE - Strategy, SWOT and Corporate Finance Report Summary Zalando SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Mckinsey & Company, Inc.
    Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bharat Petroleum Corporation Limited:企業の戦略・SWOT・財務分析
    Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Coca-Cola Amatil Limited:企業の戦略・SWOT・財務情報
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Thai Oil Public Co Ltd (TOP):企業の財務・戦略的SWOT分析
    Thai Oil Public Co Ltd (TOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Vivakor Inc (VIVK):企業の財務・戦略的SWOT分析
    Summary Vivakor Inc (Vivakor) is a technology and asset acquisition company that creates, acquires and accumulates distinct assets, intellectual properties, and various technologies. The company concentrates on precious metals extraction in the US. It also concentrates on oil extraction from shallow …
  • Berlin Packaging, LLC.:企業の戦略・SWOT・財務情報
    Berlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report Summary Berlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • OpenHydro Group Limited:電力:M&Aディール及び事業提携情報
    Summary OpenHydro Group Limited (OpenHydro) a subsidiary of DCNS S.A. designs and manufactures marine turbines for generating renewable energy from tidal streams. The company offers installation and maintenance services for the construction of tidal farms using its Open-Centre Turbine technology. It …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The University of New South Wales-製薬・医療分野:企業M&A・提携分析
    Summary The University of New South Wales (UNSW Australia) is an academic university that offer research and education services. The university’s educational services include fine arts education, design, media arts, art and design, art history, theory and art administration, social sciences, enginee …
  • Cementir Holding SpA:企業の戦略・SWOT・財務情報
    Cementir Holding SpA - Strategy, SWOT and Corporate Finance Report Summary Cementir Holding SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aldermore Bank plc:企業の戦略・SWOT・財務情報
    Aldermore Bank plc - Strategy, SWOT and Corporate Finance Report Summary Aldermore Bank plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務分析
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Assertio Therapeutics Inc (ASRT):企業の財務・戦略的SWOT分析
    Assertio Therapeutics Inc (ASRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Orbis S.A.:戦略・SWOT・企業財務分析
    Orbis S.A. - Strategy, SWOT and Corporate Finance Report Summary Orbis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Celina Insurance Group:企業の戦略・SWOT・財務情報
    Celina Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Celina Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Avangrid Inc (AGR):企業の財務・戦略的SWOT分析
    Avangrid Inc (AGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies is a medical device company that provides disposable products. The company’s products line comprise HD-Q membrane adsorbers and bind-elute products. Its HD-Q membrane adsorbers finds application in single-use flow-through p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆